Osteoporosis Medical Management

download Osteoporosis Medical Management

of 15

Transcript of Osteoporosis Medical Management

  • 8/8/2019 Osteoporosis Medical Management

    1/15

    OSTEOPOROSIS

    Medical Management

  • 8/8/2019 Osteoporosis Medical Management

    2/15

    PRIMARY MEDICAL

    MANAGEMENT

    Drug Therapy

    Surgical Management, Casts,

    Moulds(Possibly due toFractures)

  • 8/8/2019 Osteoporosis Medical Management

    3/15

    SECONDARY MEDICALMANAGEMENT

    The principles of management are :

    1. Prevention and control of risk factors. 2. Management of menopause.

    3. Musculoskeletal rehabilitation

    (Weight Bearing exercises)

    4. Lifestyle Modificationhttp://medind.nic.in/jac/t02/i2/jact02i2p128.pdf

  • 8/8/2019 Osteoporosis Medical Management

    4/15

    Drug therapy

    The drugs used in the treatment can be

    classified into two main groups:

    Antiresorptive drugs

    Formation stimulating drug

  • 8/8/2019 Osteoporosis Medical Management

    5/15

    ANTIRESORPTIVE DRUGS These agents act by decreasing bone resorption

    Calcium and vitamin D

    They act by increasing mineralization of bone, and they are effectiveeven if started very late.

    Calcium and vitamin D are more effective if taken in combination.

    Calcium alone is effective, but vitamin D is not.

    If vitamin D deficiency is due to lack of exposure to sunlight thendietary vitamin D supplementation with ergocalciferol or

    cholecalciferol will suffice. But if defect is in the renal synthesis of I-25

    dihydroxy vitamin D (calcitrol) then exogenous

    calcitrol may be required.

  • 8/8/2019 Osteoporosis Medical Management

    6/15

    Calcitonin Osteoclasts have calcitonin receptors.

    Calcitonin rapidly inhibits the action of osteoclasts resulting in

    decreased bone resorption. It is also effective in steroid induced osteoporosis in men.

    Calcitonin is commonly used in post-traumatic situationsbecause of its inherent centrally acting analgesic effect, whichis comparable to NSAIDs

    and other strong analgesics. It is less effective in preventing cortical bone

    loss than cancellous bone loss

    Side effsct are few, such as, flushing of face and nausea

    ANTIRESORPTIVE DRUGS

  • 8/8/2019 Osteoporosis Medical Management

    7/15

    Bisphosphonate increases cell death and decreases bone resorption

    leading to increased BMD and reduced fracture rate. They cause esophagitis and gastrointestinal irritationwhich can be avoided by taking it with large amountof water and remaining upright for at least 30 minutesand usually taken half

    an hour before mealtime. The optimal period of therapy is not

    known but should be given on long term basis.

    ANTIRESORPTIVE DRUGS

  • 8/8/2019 Osteoporosis Medical Management

    8/15

    Sodium fluoride

    . It acts by stimulating osteoblast proliferation

    and function. Gastric irritation and painful extremities are

    common side effects.

    FDA does not as yet approve them for treatingosteoporosis.

    Formation Stimulating Drugs

  • 8/8/2019 Osteoporosis Medical Management

    9/15

    Parathyroid hormone (PTH)

    It prevents bone loss associated with estrogen

    deficient state. PTH has been shown to increase bone formation by

    decreasing the apotosis of osteoblast

    New onset or worsening of backache was also

    reduced. Loss of height was also less with PTH therapy

    Formation Stimulating Drugs

  • 8/8/2019 Osteoporosis Medical Management

    10/15

    Anabolic steroids

    : The androgenic properties of these agents are

    responsible for effect on bone formation

    Formation Stimulating Drugs

  • 8/8/2019 Osteoporosis Medical Management

    11/15

    Management protocolsPain relief and general measures after fracture : The general measures include adequate bed rest, local heat, analgesics,

    calcitonin, avoiding constipation, and lumbar support corset.

    Once pain subsides, initiate the patient into an exercise programme to

    correct postural deformity and increase muscle tone and BMD.

    Life-style modification :

    It includes identification and elimination/correction of modifiable riskfactors.

    Avoid lifting heavy weights and forward bending.

    All patients should be given calcium and vitamin D

    supplementation and encouraged to join regular exercise

    or rehabilitation programme

  • 8/8/2019 Osteoporosis Medical Management

    12/15

    KEY POINTS

    Type I or post-menopausal Antiresorptive

    Drugs

    Alternative: Calcitonin, SERMs, andbisphosphonate

    Type II or age related calcium and vitamin D

    and analogues

    Note: Calcitonin can be given for analgesic

    effect

  • 8/8/2019 Osteoporosis Medical Management

    13/15

    Idiopathic osteoporosis in premenopausal

    women Calcium and Vitamin D

    Young or middle-aged men

    If testosterone is low, give testosterone

    enanthate IM at 4 week intervals. Calcium, vitamin D supplementation, and risk

    factors modification

  • 8/8/2019 Osteoporosis Medical Management

    14/15

    Glucocorticoid-induced osteoporosis Maintain calcium and vitamin D intake, askpatient to do regular exercise, and target risk

    modification.

    Musculoskeletal and psychological

    Rehabilitation : refer to a trained physicaltherapist, psychologist, and

    nutritionist for consultation

  • 8/8/2019 Osteoporosis Medical Management

    15/15

    End of Slideshow

    Primary reference: Osteoporosis Medical

    Management by Umesh Kansra